Advertising Survey

We would like your input on how advertising is currently used in the site.

Please take this short survey to help us out.

Hide this message

Junctional Naevus

This PatientPlus article is written for healthcare professionals so the language may be more technical than the condition leaflets. You may find the abbreviations list helpful.

Description

These are a form of melanocytic naevus (or mole) where the accumulation of melanocytes is located predominantly at the dermo-epidermal junction, hence their name. Junctional naevi are often quite darkly pigmented and are macular or very thinly papular with only minimal elevation above the level of the skin.1 They are an acquired lesion and as they age they can change their characteristics to that of a compound naevus, where there are accumulations of melanocytes in the dermis and at the dermo-epidermal junction, which causes the lesion to become increasingly papular.

They occur at any site on the body and are regularly shaped, usually round or oval. They are most often uniform in colour and range in pigmentation from light to dark brown. They are usually <7 mm or so in diameter. They are benign lesions but have the potential to undergo transformation to malignant melanoma.

Epidemiology

There are no reliable figures for the prevalence of melanocytic naevi in the general population but they are exceedingly common in congenital and acquired form. Their prevalence is so high that some believe they cannot even be considered an abnormality or pathological entity, as most people with light-coloured skin will have at least a few.1 They are much more common in ethnic groups with light skin but they still have an appreciable prevalence in those with more pigmented skin. The true frequency of malignant transformation to melanoma is unknown but thought to be very low (certainly <1 % over a lifetime) for small junctional naevi.

Visual appearance

Close-up images of a compound naevus and junctional naevus

JUNCTIONAL NAEVUS -JUNCTIONAL AND COMPOUND NAEVI (DIS57.jpg)

Close-up image of a junctional naevus

JUNCTIONAL NAEVUS -CLOSE UP (DIS59.jpg)

Presentation

Symptoms

  • Establish if the lesion is congenital or acquired (junctional naevi are usually acquired).
  • When a lesion presents medically it is important to ascertain whether there have been any associated symptoms such as:
    • Enlargement
    • Change in shape or size
    • Change in pigmentation
    • Itchiness/pain/irritation
    • Bleeding

Signs

  • Examine the lesion in bright light, preferably daylight if available.
  • Use drawings or photography to note the site(s), size and pigmentation of the lesion(s).
  • Assess for Asymmetry of the lesion, Border (any irregularity?), Colour of lesion, Diameter of the lesion.
  • Establish that the lesion has the typical pattern of pigmentation and is not significantly raised from the level of the skin, to confirm as a junctional naevus.
  • Distinguish from other similar pigmented macules that affect the skin:
    • Freckles (ephelides) are usually multiple, small and darken after sunlight exposure.
    • Café-au-lait spots are usually larger, lighter in pigmentation and have very distinct borders.
    • Lentigines are small, sharply circumscribed and pigmented, surrounded by normal-appearing skin and tend to be multiple, lighter brown and more irregular in shape.
    • Melanoma tends to be darker, have an irregular border, be asymmetrical and have recently grown.
    • Any lesion that has increased in size, become irregular in shape, changed its colour, become heterogeneous in pigmentation, become inflamed, bled, crusted or oozed suggests a possibility of melanoma and should be assessed by excision biopsy.

Differential diagnosis

Investigations

  • No investigations are necessary in the case of a simple acquired junctional naevus that has not undergone any recent change.
  • Some dermatologists may use dermoscopy to try and distinguish the nature of pigmented lesions.2 The value of this technique has been proved by three meta-analyses.3
  • In vivo confocal microscopy (which produces digital images of a patient’s skin with cellular detail similar to that obtained from histology of surgical biopsies) is an emerging technology that promises great benefits in the identification of skin lesions.4
  • If there is any suspicion of malignant melanoma then the investigation of choice is excision biopsy.
  • Perform excision biopsy or refer if there are ≥2–3 of the following features:
    • Size greater than 7 mm
    • History of itching
    • Evidence of inflammation or redness
    • Increase in diameter
    • Change in colour, particularly streaming of pigment at edges
    • Irregular or asymmetrical shape
    • Previous oozing, crusting or bleeding.

Management

  • If the diagnosis of junctional naevus is clear and there has been no change in a long-standing lesion, then reassurance and monitoring of the lesion are all that is usually required.
  • Where there is any doubt as to the diagnosis, perform excision biopsy or refer for dermatological advice. One study suggests that GPs need more training in the recognition of potentially malignant lesions.5
  • Perform excision biopsy whenever the lesion has:
    • Grown
    • Become symptomatic
    • Developed asymmetry
    • Developed an irregular border
    • Altered its degree or pattern of pigmentation
    • Developed satellite lesions

Complications and prognosis

Junctional naevi are, on the whole, benign lesions with a very low risk of transformation to malignant melanoma. Patients with multiple lesions and high sun-exposure or episodes of sunburn may be at higher risk of developing melanoma and should be warned of potentially alarming symptoms and reviewed if there is any cause for concern.


Document references

  1. McCalmont T; Nevi, Melanocytic. eMedicine, updated October 2008.
  2. Braun RP, Rabinovitz HS, Oliviero M, et al; Dermoscopy of pigmented skin lesions. J Am Acad Dermatol. 2005 Jan;52(1):109-21. [abstract]
  3. Braun RP, Oliviero M, Kolm I, et al; Dermoscopy: what's new? Clin Dermatol. 2009 Jan-Feb;27(1):26-34. [abstract]
  4. Psaty EL, Halpern AC; Current and emerging technologies in melanoma diagnosis: the state of the art. Clin Dermatol. 2009 Jan-Feb;27(1):35-45. [abstract]
  5. Pockney P, Primrose J, George S, et al; Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial. Br J Cancer. 2009 Jan 13;100(1):24-7. [abstract]

Internet and further reading

Acknowledgements

EMIS is grateful to Dr Laurence Knott for writing this article and to Dr Sean Kavanagh for earlier versions. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
Document ID: 4068
Document Version: 21
Document Reference: bgp26001
Last Updated: 26 Feb 2009
Provide feedback